Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.

Epidemiologic and animal studies have linked pancreatic cancer growth with fat intake, especially unsaturated fats. Arachidonic acid release from membrane phospholipids is essential for tumor cell proliferation. Lipoxygenases (LOX) constitute one pathway for arachidonate metabolism, but their role in pancreatic cancer growth is unknown. The expression of 5-LOX and 12-LOX as well as their effects on cell proliferation was investigated in four human pancreatic cancer cell lines (PANC-1, MiaPaca2, Capan2, and ASPC-1). Expression of 5-LOX and 12-LOX mRNA was measured by nested RT-PCR. Effects of LOX inhibitors and specific LOX antisense oligonucleotides on pancreatic cancer cell proliferation were measured by (3)H-thymidine incorporation. Our results showed that (1) 5-LOX and 12-LOX were expressed in all pancreatic cancer cell lines tested, while they were not detectable in normal human pancreatic ductal cells; (2) both LOX inhibitors and LOX antisense markedly inhibited cell proliferation in a concentration-dependent and time-dependent manner; (3) the 5-LOX and 12-LOX metabolites 5-HETE and 12-HETE as well as arachidonic and linoleic acids directly stimulated pancreatic cancer cell proliferation; (4) LOX inhibitor-induced growth inhibition was reversed by 5-HETE and 12-HETE. The current studies indicate that both 5-LOX and 12-LOX expression is upregulated in human pancreatic cancer cells and LOX plays a critical role in pancreatic cancer cell proliferation. LOX inhibitors may be valuable for the treatment of pancreatic cancer.

[1]  C. Thron,et al.  Carcinogen-induced lesions in the rat pancreas: effects of varying levels of essential fatty acid. , 1985, Cancer research.

[2]  J. Summerton,et al.  Uncharged stereoregular nucleic acid analogs: 2. Morpholino nucleoside oligomers with carbamate internucleoside linkages. , 1989, Nucleic acids research.

[3]  T. Ruzicka.  Eicosanoids and the Skin , 1990 .

[4]  H E Morton,et al.  MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. , 1990, The Journal of biological chemistry.

[5]  W. Glasgow,et al.  Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblasts. Differential effects in tumor suppressor gene (+) and (-) phenotypes. , 1992, The Journal of biological chemistry.

[6]  L. Tertoolen,et al.  Epidermal growth factor—induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products , 1993, Cell.

[7]  J. Tímár,et al.  Regulation of melanoma‐cell motility by the lipoxygenase metabolite 12‐(S)‐hete , 1993, International journal of cancer.

[8]  K. Honn,et al.  Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process. , 1994, Cancer research.

[9]  Huei-Wen Chen,et al.  Effects of baicalein and esculetin on transduction signals and growth factors expression in T-lymphoid leukemia cells. , 1994, European journal of pharmacology.

[10]  K. Honn,et al.  Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. , 1994, Experimental cell research.

[11]  B. Liu,et al.  Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. , 1994, Cancer research.

[12]  E. Rozengurt,et al.  Preferential inhibition of platelet-derived growth factor-stimulated DNA synthesis and protein tyrosine phosphorylation by nordihydroguaiaretic acid. , 1994, The Journal of biological chemistry.

[13]  K. Honn,et al.  12‐Lipoxygenase, 12(S)‐HETE, and Cancer Metastasis a , 1994, Annals of the New York Academy of Sciences.

[14]  L. Boros,et al.  Reversal of enhanced pancreatic cancer growth in diabetes by insulin. , 1995, Surgery.

[15]  J. Norton,et al.  Management of pancreatic carcinoma. , 1995, Surgical oncology.

[16]  C. Schalkwijk,et al.  Epidermal growth factor (EGF) induces serine phosphorylation-dependent activation and calcium-dependent translocation of the cytosolic phospholipase A2. , 1995, European journal of biochemistry.

[17]  D. Grignon,et al.  Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. , 1995, Urology.

[18]  F. McCormick,et al.  Rac mediates growth factor-induced arachidonic acid release , 1995, Cell.

[19]  B. Rigas,et al.  Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. , 1995, Biochimica et biophysica acta.

[20]  M. Korc,et al.  Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters. , 1996, Carcinogenesis.

[21]  K. Honn,et al.  Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Summerton,et al.  A simple method for delivering morpholino antisense oligos into the cytoplasm of cells. , 1996, Antisense & nucleic acid drug development.

[23]  C. Myers,et al.  Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. , 1997, Biochemical and biophysical research communications.

[24]  J. Harris,et al.  Five-lipoxygenase inhibitors reduce Panc-1 survival: the mode of cell death and synergism of MK886 with gamma linolenic acid. , 1998, Anticancer research.

[25]  T. Rabe,et al.  Influence of 5-Lipoxygenase on in vitro Growth of Human Mammary Carcinoma Cell Line MCF-7 , 1998, Gynecologic and Obstetric Investigation.

[26]  K. Ingolfsdottir,et al.  Natural Products: Anti‐proliferative Effects of Lichen‐derived Inhibitors of 5‐Lipoxygenase on Malignant Cell‐lines and Mitogen‐stimulated Lymphocytes , 1998, The Journal of pharmacy and pharmacology.